Author Archives: admin

Global Cell Therapy Systems Market Projected to Witness a Measurable Downturn; COVID-19 Outbreak Remains a Threat to Growth in the Near Future…

By adminJuly 31, 2020Stem Cell Doctors

With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and medical device industries. FMI deploys digital intelligence solutions to offer compelling insights to report buyers that help them in overcoming market challenges, especially at the time of a crisis. Our dedicated team of professionals performs an extensive survey for gathering accurate information associated with the market.

FMI, in its upcoming business report, elaborates the historical and current scenario of the global Cell Therapy Systems market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Crucial information and forecast statistics covered in the Cell Therapy Systems market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

For more insights into the Market, request a sample of this[emailprotected] https://www.futuremarketinsights.com/reports/sample/rep-gb-5050

COVID-19 Impact Analysis on Cell Therapy Systems Market

The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Cell Therapy Systems market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Cell Therapy Systems market.

Following governments measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMIs report includes an interesting chapter on preliminary impact of the COVID-19 on the Cell Therapy Systems market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Why Choose Future Market Insights

Discounted prices for new customers! Offer expires soon!

For Information On The Research Approach Used In The Report, Request [emailprotected] https://www.futuremarketinsights.com/askus/rep-gb-5050

Systemic Lupus Erythematous Sle Drugs Market: Segmentation

Valuable information covered in the FMIs Systemic Lupus Erythematous Sle Drugs market report has been segregated into key segments and sub-segments.

By Products

By Application

Cell Therapy Systems Market: Competition Analysis

The FMIs study presents a comprehensive analysis of global, regional, and country-level players active in the Cell Therapy Systems market. Competitive information detailed in the Cell Therapy Systems market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Cell Therapy Systems market report.

Key players covered in the report include:

Important Questions Answered in the Cell Therapy Systems Market Report

Request for Covid19 Impact [emailprotected] https://www.futuremarketinsights.com/covid19/rep-gb-5050

Key Offerings of the Report

View original post here:
Global Cell Therapy Systems Market Projected to Witness a Measurable Downturn; COVID-19 Outbreak Remains a Threat to Growth in the Near Future...

Animal Stem Cell Therapy Market to Witness a Pronounce Growth During 2025: MediVet Biologic, VETSTEM BIOPHARMA, J-ARM – Owned

By adminJuly 31, 2020Stem Cell Treatment

A recent report published by Research Reports Inc on the Animal Stem Cell Therapy market is a detailed assessment of the most important market dynamics.

Get Free Sample Copy of Animal Stem Cell Therapy Report 2020: http://www.researchreportsinc.com/report-sample/552373

(Use Corporate eMail ID So Immediately Accessible With Higher Priority.)

The Animal Stem Cell Therapy Market research report summaries various key players dominating the market. It includes several aspects covering the overview of key firms, their monetary summary, business tactics, and the recent advancements in these firms. Animal Stem Cell Therapy report offers a complete industry analysis. In this analysis, the end-users are provided with the market size, growth and value chain analysis. The Animal Stem Cell Therapy report represents a comprehensive view of the global Animal Stem Cell Therapy Market. It employs various methodological techniques such as five Porters analysis to provide a competitive outlook.

The Major Players Covered In This Report:

MediVet Biologic, VETSTEM BIOPHARMA, J-ARM, Celavet, Magellan Stem Cells, U.S. Stem Cell, Cells Power Japan, ANIMAL CELL THERAPIES, Animal Care Stem, Cell Therapy Sciences, VetCell Therapeutics, Animacel, Aratana Therapeutics

The competition section of the Animal Stem Cell Therapy market features profiles of key players operating in the Animal Stem Cell Therapy market based on company shares, differential strategies, Animal Stem Cell Therapy product offerings, marketing approach, and company dashboard. Research studies have been conducted on Animal Stem Cell Therapy market size for the forecast period 2020 to 2025. The Animal Stem Cell Therapy market report offers a comprehensive evaluation of the business opportunities prevailing in the Animal Stem Cell Therapy market along with insights on the trend, market dynamics, Animal Stem Cell Therapy market size opportunity analysis, and Animal Stem Cell Therapy market competition.

The Animal Stem Cell Therapy report covers the following Types:

On the basis of applications, the market covers:

Get Discount on this Report: http://www.researchreportsinc.com/check-discount/552373

The research report includes the latest updates about the COVID-19 impact on the Animal Stem Cell Therapy market. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

The Animal Stem Cell Therapy Market report wraps:

The report also emphasizes the initiatives undertaken by the businesses operating within the market including product innovation, product launches, and technological development to assist their organization offer simpler products in the market. It also studies notable business events, including corporate deals, mergers and acquisitions, joint ventures, partnerships, product launches, and brand promotions.

See original here:
Animal Stem Cell Therapy Market to Witness a Pronounce Growth During 2025: MediVet Biologic, VETSTEM BIOPHARMA, J-ARM - Owned

Flow Cytometry Market 2020 | Research Objectives and Methodology, Growth Analysis, Top Manufacturers Sales, and Cost Structures Forecast 2024 – Owned

By adminJuly 31, 2020Stem Cell Clinics

Agilent Technologies

Report Highlights:

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13999638

Key Market Trends:

Stem Cell Therapy is Expected to Hold the Largest Market Share, by Application

The stem cell therapy segment is believed to have the largest market size and is expected to witness a CAGR of 8.4% during the forecast period.

The key reasons for the large market share include the extensive use of flow cytometry for effective diagnosis and early detection of numerous diseases that have helped the market to gain immense shares. There has been a growing market penetration in stem cell research, adoption of recombinant DNA technology for antibody production, and the evolution of tandem flow cytometry technologies that are expected to offer growth opportunities for the players operating in the flow cytometry market during the forecast period.

Though flow cytometry has also found many applications in several stages of drug discovery, its routine widespread use for high throughput drug screening has been limited. This is unlike analogous technology, automated high content imaging (HCI), which, in terms of drug screening, is an established technology that is common in screening laboratories.

North America Dominates the Market and is Expected to Continue its Lead over the Forecast Period

North America holds a major share of the flow cytometry market and is projected to continue over the next few years. An increasing prevalence of diseases and the rising contribution from the US market are expected to help the market grow. In addition, there has also been a rise in the expansion of novel products that are anticipated to offer new growth opportunities in the coming years.

The Report Covers:

Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/13999638

Detailed TOC of Flow Cytometry Market Report 2020-2024:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Use of Flow Cytometry in Stem Cell Research 4.2.2 Emergence and Commercial Applications of New Technologies in the Field of Flow Cytometry 4.2.3 Increasing Applications of Flow Cytometry in Clinical Research 4.3 Market Restraints 4.3.1 Lack of Awareness about the Potential Benefits of Flow Cytometry Techniques 4.3.2 Expensive Equipment 4.4 Industry Attractiveness Porters Five Forces Analysis 4.4.1 Threat of New Entrants 4.4.2 Bargaining Power of Buyers/Consumers 4.4.3 Bargaining Power of Suppliers 4.4.4 Threat of Substitute Products 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 Product Type 5.1.1 Instrument 5.1.2 Fluorophore 5.1.3 Kit and Reagent 5.1.4 Software 5.1.5 Other Product Types 5.2 Technology 5.2.1 Cell-based Flow Cytometry 5.2.2 Bead-based Flow Cytometry 5.3 Application 5.3.1 Oncology 5.3.2 Drug Discovery 5.3.3 Disease Diagnosis 5.3.4 Stem Cell Therapy 5.3.5 Organ Transplantation 5.3.6 Hematology 5.3.7 Other Applications 5.4 By End User 5.4.1 Hospitals and Clinics 5.4.2 Academia and Research Institutes 5.4.3 Pharmaceutical and Biotechnology Companies 5.4.4 Other End Users 5.5 Geography 5.5.1 North America 5.5.1.1 US 5.5.1.2 Canada 5.5.1.3 Mexico 5.5.2 Europe 5.5.2.1 Germany 5.5.2.2 UK 5.5.2.3 France 5.5.2.4 Italy 5.5.2.5 Spain 5.5.2.6 Rest of Europe 5.5.3 Asia-Pacific 5.5.3.1 China 5.5.3.2 Japan 5.5.3.3 India 5.5.3.4 Australia 5.5.3.5 South Korea 5.5.3.6 Rest of Asia-Pacific 5.5.4 Middle East & Africa 5.5.4.1 GCC 5.5.4.2 South Africa 5.5.4.3 Rest of Middle East & Africa 5.5.5 South America 5.5.5.1 Brazil 5.5.5.2 Argentina 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Becton, Dickinson and Company 6.1.2 Beckman Coulter 6.1.3 EMD Millipore (Merck KGaA) 6.1.4 Bio-Rad Laboratories 6.1.5 Luminex Corporation 6.1.6 Life Technologies 6.1.7 Miltenyi Biotech 6.1.8 Sysmex Partec GmbH 6.1.9 Agilent Technologies

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Foil Winding Machines Market 2020 Industry Outlook by Business Share, Industry Price Trend, Size Estimation, Latest Research Report by Business Analysis and Forecast Research till 2025

Metallized BOPP Film Market Size of Key Players Research by Global Business Opportunities, Industry Growth Rate, Demand Status, Regional Analysis, Forecast to 2020-2024

Military Aerial Refueling Tanker Market Size with Current Industry Scenario, Latest Opportunity, Top Key Players, Industry Share with Growth Analysis Forecast to 2020-2024 with COVID-19 Analysis

Cloud Analytics Market Development Analysis Contributing Top Vendor Landscape 2020 Global Share and Size, Future Plans by Top Key Players and Economic Growth 2025 with COVID-19 Impact

Home Dressing Table Market Share Value 2020 Industry Top Players, Trends, Global Growth Rate by Size Expansion Strategies by 2026 Report Includes COVID-19 Analysis

Walnut Milk Market 2020 Global Business Growth, Industry Size, Share, Revenue, Trends, Global Market Demand Penetration and Forecast to 2025

New Trends of Stem Cell Banking Market with Worldwide Industry Analysis to 2025 – Owned

By adminJuly 31, 2020Stell Cell Research

The report on the Stem Cell Banking market provides a birds eye view of the current proceeding within the Stem Cell Banking market. Further, the report ponders over the various factors that are likely to impact the overall dynamics of the Stem Cell Banking market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more.

As per the report, the global Stem Cell Banking market is expected to register a CAGR growth of ~XX% during the assessment period and attain a value of ~US$XX by the end of 2029. Further, the report suggests that the growth of the Stem Cell Banking market is largely influenced by a range of factors including, emphasis on innovation by market players, surging investments towards R&D activities, and favorable regulatory policies among others.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2644328&source=atm

Doubts Related to the Stem Cell Banking Market Addressed in the Report:

Competition Landscape

The report provides critical insights related to the prominent companies operating in the Stem Cell Banking market. The revenue generated, market presence, product range, and financials of each company is included in the report.

Regional Landscape

The regional landscape section of the report provides resourceful insights related to the scenario of the Stem Cell Banking market in different regions. Further, the market attractiveness analysis of each region provides players a clear understanding of the overall growth potential in each regional market.

End-User Analysis

The report provides an in-depth understanding of the various end-users of the Stem Cell Banking along with the market share, size, and revenue generated by each end-user.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2644328&source=atm

Regional and Country-level Analysis The report offers an exhaustive geographical analysis of the global Stem Cell Banking market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026. Competition Analysis In the competitive analysis section of the report, leading as well as prominent players of the global Stem Cell Banking market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cell Banking market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cell Banking market. The following players are covered in this report: CCBC CBR ViaCord Esperite Vcanbio Boyalife LifeCell Crioestaminal RMS Regrow Cordlife PBKM FamiCord cells4life Beikebiotech StemCyte Cryo-cell Cellsafe Biotech PacifiCord Americord Krio Familycord Cryo Stemcell Stemade Biotech Stem Cell Banking Breakdown Data by Type Umbilical Cord Blood Stem Cell Embryonic Stem Cell Adult Stem Cell Other Stem Cell Banking Breakdown Data by Application Diseases Therapy Healthcare

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2644328&licType=S&source=atm

Important Information that can be extracted from the Report:

Here is the original post:
New Trends of Stem Cell Banking Market with Worldwide Industry Analysis to 2025 - Owned

Cerus Corporation Announces a Five-Year Tender Award by the Hong Kong Red Cross Blood Transfusion Service for INTERCEPT Blood Systems – BioSpace

By adminJuly 31, 2020Stem Cell Medicine

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq:CERS) today announced it has been awarded a five-year tender by the Hong Kong Red Cross Blood Transfusion Services (BTS) for INTERCEPT Blood System for platelets. The Hong Kong Red Cross BTS is the only public institution providing blood to all hospitals, public and private, in Hong Kong.

Following a thorough selection process, we are pleased to be selected by the Hong Kong Red Cross BTS to supply INTERCEPT Blood System for platelets, said Pascal Maillard, Cerus vice president of commercial operations for the Asia Pacific region. INTERCEPT for platelets provides a robust, broad-spectrum inactivation, reducing the risks of transfusion-transmitted infections and thereby enhancing patient care.

This is an important contract for Cerus, continued Maillard. The Hong Kong Red Cross BTS is a member of the influential Asia Pacific Blood Network (APBN) and a key opinion leader globally. This tender award presents a unique opportunity to expand the use of INTERCEPT in Asia-Pacific, a region that represents a significant market growth opportunity for Cerus.

The tender award builds upon the prior experience of the Hong Kong Red Cross BTS with the INTERCEPT Blood System for platelets. The Hong Kong Red Cross BTS, in collaboration with the Queen Mary Hospital, conducted a clinical study successfully transfusing INTERCEPT treated platelet components prepared without leukocyte reduction, without bacterial screening, and without gamma irradiation to allogeneic Hematopoietic Stem Cell Transplant (HSCT) patients (Sim, Tsoi et al. 2019).

This innovative study conducted by the Hong Kong Red Cross BTS and Queen Mary Hospital has the potential to change how patients are supported with platelet transfusions, said Dr. Laurence Corash, Cerus chief scientific officer. The study indicated that INTERCEPT treatment could potentially replace leukocyte filtration, a common practice to reduce the incidence of febrile transfusion reactions, alloimmunization, and cytomegalovirus (CMV) infection. The INTERCEPT platelet system has already demonstrated widespread replacement of bacterial screening, gamma irradiation, and CMV serology in the EU and U.S.

The Hong Kong Red Cross BTS recently completed renovations and is a state-of-the-art facility that manufactures approximately 40,000 platelet doses per year, a portion of which will be treated with INTERCEPT.

Sim, J., W. C. Tsoi, et al. (2019). "Transfusion of pathogen-reduced platelet components without leukoreduction." Transfusion 59(6): 1953-1961.

ABOUT CERUS

Cerus Corporation is dedicated solely to safeguarding the worlds blood supply and aims to become the preeminent global blood products company. Based in Concord, California, our employees are dedicated to deploying and supplying vital technologies and pathogen-protected blood components for blood centers, hospitals and ultimately patients who rely on safe blood. With the INTERCEPT Blood System, we are focused on protecting patients by delivering the full complement of reliable products and expertise for transfusion medicine. Cerus develops and markets the INTERCEPT Blood System and remains the only company in the blood transfusion space to earn both CE Mark and FDA approval for pathogen reduction of both platelet and plasma components. Cerus currently markets and sells the INTERCEPT Blood System in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT Red Blood Cell system is in clinical development. For more information about Cerus, visit http://www.cerus.com and follow us on LinkedIn.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Forward Looking Statements

Except for the historical statements contained herein, this press release contains forward-looking statements concerning Cerus belief that the INTERCEPT Blood System has the potential to change how patients are supported with platelet transfusions and to potentially replace leukocyte filtration, and other statements that are not historical facts. Actual results could differ materially from these forward-looking statements as a result of certain factors, including, without limitation: risks related to Cerus ability to demonstrate to the transfusion medicine community and other health care constituencies that pathogen reduction and the INTERCEPT Blood System is safe, effective and economical; the risk that applicable regulatory authorities and healthcare practitioners may disagree with Cerus interpretations of the data from its clinical studies; as well as other risks detailed in Cerus filings with the Securities and Exchange Commission, including Cerus Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 5, 2020. In addition, to the extent that the COVID-19 pandemic adversely affects Cerus business and financial results, it may also have the effect of heightening many of the other risks and uncertainties described above. Cerus disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200730005316/en/

Stem Cells Market is expected to pick up in healthy CAGR by 2020-2025 Top companies | Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell,…

By adminJuly 31, 2020Embryonic Stem Cells

Stem Cells Market Overview 2020 2025

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The risingtechnology in Stem Cells Marketis also depicted in thisresearchreport. Factors that are boosting the growth of the market, and giving a positive push to thrive in the global market is explained in detail.

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells). Both types are generally characterized by their potency, or potential to differentiate into different cell types (such as skin, muscle, bone, etc.). This report studies the Stem Cell Therapy. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/13815

Key Competitors of the Global Stem Cells Market are: , Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, MolMed, Takeda (TiGenix)

Historical data available in the report elaborates on the development of the Stem Cells on national, regional and international levels. Stem Cells Market Research Report presents a detailed analysis based on the thorough research of the overall market, particularly on questions that border on the market size, growth scenario, potential opportunities, operation landscape, trend analysis, and competitive analysis.

Major Product Types covered are: Allogeneic Autologous

Major Applications of Stem Cells covered are: Musculoskeletal Disorder Wounds & Injuries Cornea Cardiovascular Diseases Others

This study report on global Stem Cells market throws light on the crucial trends and dynamics impacting the development of the market, including the restraints, drivers, and opportunities.

To get this report at a profitable rate.: https://reportsinsights.com/discount/13815

The fundamental purpose of Stem Cells Market report is to provide a correct and strategic analysis of the Stem Cells industry. The report scrutinizes each segment and sub-segments presents before you a 360-degree view of the said market.

Market Scenario:

The report further highlights the development trends in the global Stem Cells market. Factors that are driving the market growth and fueling its segments are also analyzed in the report. The report also highlights on its applications, types, deployments, components, developments of this market.

Highlights following key factors:

:-Business descriptionA detailed description of the companys operations and business divisions. :-Corporate strategyAnalysts summarization of the companys business strategy. :-SWOT AnalysisA detailed analysis of the companys strengths, weakness, opportunities and threats. :-Company historyProgression of key events associated with the company. :-Major products and servicesA list of major products, services and brands of the company. :-Key competitorsA list of key competitors to the company. :-Important locations and subsidiariesA list and contact details of key locations and subsidiaries of the company. :-Detailed financial ratios for the past five yearsThe latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Our report offers:

Market share assessments for the regional and country level segments. Market share analysis of the top industry players. Strategic recommendations for the new entrants. Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets. Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations). Strategic recommendations in key business segments based on the market estimations. Competitive landscaping mapping the key common trends. Company profiling with detailed strategies, financials, and recent developments. Supply chain trends mapping the latest technological advancements.

Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://reportsinsights.com/industry-forecast/Stem-Cells-Market-13815

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

Read the rest here:
Stem Cells Market is expected to pick up in healthy CAGR by 2020-2025 Top companies | Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell,...

Rheumatoid Arthritis Stem Cell Therapy Market Shares, Strategies and Forecast Worldwide, 2018 to 2028 Bulletin Line – Bulletin Line

By adminJuly 31, 2020Stem Cell Treatment

Fact.MR, in its recently published market research report, provides an in-depth analysis of the Rheumatoid Arthritis Stem Cell Therapy market included the anticipated growth pattern of the market over the forecast period (2019-2029). A detailed assessment of the various micro and macro-economic factors that are likely to shape the course of the Rheumatoid Arthritis Stem Cell Therapy market over the next decade is enclosed in the report. The study suggests that the Rheumatoid Arthritis Stem Cell Therapy market is expected to register a CAGR growth of XX% over the forecast period primarily driven by factors including factor 1, factor 2, factor 3, and factor 4.

Further, the methodical and systematic approach adopted by the analysts while curating the report ensures that the data in the report is insightful, relevant, and a valuable tool for our clients to gain a competitive advantage in the current and future market landscape.

Request Sample Report @ https://www.factmr.co/connectus/sample?flag=S&rep_id=1001

Competitive assessment

The competitive assessment included in the report throws light on the business strategies incorporated by leading market players operating in the Rheumatoid Arthritis Stem Cell Therapy market. The comprehensive study provides a birds eye view of the business operations of top-tier market players along with relevant graphs, figures, and tables.

Regional analysis

The regional analysis section touches upon the market scenario in the various geographies worldwide and the factors that are projected to influence the market dynamics in each region. The impact of the economic and political policies of different countries in each region is discussed in the report in detail.

End Use study

The report bifurcates the Rheumatoid Arthritis Stem Cell Therapy market on the basis of end-use and tracks the Y-o-Y growth of each end use segment.

Competitive landscape

Request Methodology On This Report @ https://www.factmr.co/connectus/sample?flag=RM&rep_id=1001

Important questions answered in the report:

Why Choose Fact.MR?

Ask analyst about this report at https://www.factmr.co/connectus/sample?flag=AE&rep_id=1001

See original here:
Rheumatoid Arthritis Stem Cell Therapy Market Shares, Strategies and Forecast Worldwide, 2018 to 2028 Bulletin Line - Bulletin Line

Crowdfunding to the rescue for this cancer patient – Social News XYZ

By adminJuly 30, 2020Stem Cell Doctors

Home IANS Life Crowdfunding to the rescue for this cancer patient

Posted By: Gopi July 30, 2020

By Siddhi Jain

New Delhi, July 30 (SocialNews.XYZ) Cancer takes innumerable lives each year, and so does the unavailability of cancer treatment due to lack of funds. 33-year-old Nushafreen Palsetia, a software engineer based in Mumbai, was recently diagnosed with a very aggressive form of cancer. Despite a relapse, what helped was life-saving support pouring from over 1,700 donors.

Nushafreen was first diagnosed with Non-Hodgkin Lymphoma in April 2019. After a year of enduring aggressive treatment, she tried to get back to her normal life and work. Unfortunately, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), cancer relapsed in her liver in May 2020 which was an unexpected major shock, leaving her and all of her family overwhelmed.

Doctors planned to perform an autologous (her own stem cells) bone marrow transplant in India after the chemotherapy but further tests showed involvement of the bone marrow as well. Hence, her treating doctor recommended the modern CAR-T Cell therapy treatment, available only in the USA, UK, Israel, and a few European countries.

Nushafreen's family found Israel as the most affordable option as compared to all other countries offering the treatment. They reached out to Sheba Medical Centre in Israel which estimated the medical expenses as 200,000 USD (approximately Rs 1.5 crore). The treatment will require Nushafreen to be hospitalized for a month or more for the response to treatment and immediate follow up.

As Nushafreen's family couldn't afford the high medical expenses, an ImpactGuru crowdfunding campaign was initiated. In two weeks, Nushafreen's ImpactGuru.com Page has raised over Rs 1 crore from 1750 donors. The platform raises money online for medical expenses via crowdfunding such as cancer, transplants, and accidents.

According to the co-founder and CEO of the healthcare crowdfunding platform, Piyush Jain, "Crowdfunding is driven by a culture of generosity, it allows people to raise money quickly in a hassle free manner without any payback liability. This is a new record for our platform with a single patient's family being able to raise more than Rs 1 crore. We hope Nushafreen recovers soon and more patients come forward to utilize our platform in their time of need to get the best available treatment for critical illnesses."

(Siddhi Jain can be contacted at siddhi.j@ians.in)

Source: IANS

Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.

He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.

When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.

He can be reached at gopi@socialnews.xyz

Like Loading...

Read the original here:
Crowdfunding to the rescue for this cancer patient - Social News XYZ

Scientists to speed creation of pig vaccines – FarmingUK

By adminJuly 30, 2020Stell Cell Research

Scientists want to combat African swine fever, a highly contagious, potentially fatal disease, and Porcine Reproductive and Respiratory Syndrome, found in commercial herds

Scientists are developing a method to speed the creation of vaccines for devastating pig diseases, such as African swine fever.

British researchers are aiming to establish a reliable, large-scale system to develop and test vaccines for viral infections.

Stem cell technology will be used to develop a source of white blood cells, identical to those affected by disease in pigs, which can be used to develop vaccines containing live virus.

The team, involving scientists from the Roslin Institute and the Animal and Plant Health Agency (APHA), are particularly investigating control strategies against African swine fever virus.

Results from the study are expected to shed light on how diseases such as ASF target white blood cells, and how the cells respond to infection.

The approach seeks to improve on current vaccine testing methods, which include using blood cells derived from other animal species, or from other types of cells that resemble blood cells.

Stem cells those in early stage of development, which can differentiate into blood cells hold promise as a source of blood cells as they are likely to be free of contamination with disease, leading to accurate, reliable results.

Genetic modification techniques may also enable researchers to develop more efficient production of blood cells.

This approach may also enable scientists to explore whether lab-produced blood cells are able to contain high levels of virus, making them effective for vaccine development.

In addition, the application of genome editing technology to blood and virus cells could aid understanding of the role of genes in infectivity, immune response, and resistance to disease.

Dr Tom Burdon, research group leader at Roslin Institute said: "Stem cell technology applied to vaccine development can not only speed the delivery of results but limit the need for research involving animals.

"We hope that our efforts will aid the search for effective vaccines against serious diseases, which affect millions of animals and incur great cost to farmers."

See the original post:
Scientists to speed creation of pig vaccines - FarmingUK

Arson at The Way Christian Center and The Shortage of Stem Cell Donors of Color – KPFA – 94.1FM

By adminJuly 30, 2020Stem Cell Treatment

Davey D brings us audio from todays press conference held at The Way Christian Center in Berkeley Ca. Less than 12 hours after The Way Christian Center placed a Black Lives Matter banner, someone set fire to several trash cans positioned at the back of the church. The act of arson, damaged a portion of the building (see photos below) and has created fear and anger in the community.

Later we speak with Jess Tom and Carol Gillespie about treatment for blood-related cancers, the shortage of stem cell donors of color and the need to improve the registries. Seventy percent of patients wont have a match in their families and must find an unrelated donor. Patients are more likely to match donors who share the same ethnic background, but the lack of diversity on the Be The Match national registry makes it difficult for patients to find one. The Asian American Donor Program (AADP,

Guests:

Pastor Michael McBride (known as Pastor Mike) The fire was an act of terror, said Pastor Michael McBride, who leads the 48-year-old Way Christian Church.

Pastor Michael McBride is a native of San Francisco, CA. and has been active in ministry for almost 20 years. In June 2005, Pastor McBridelaunched a new ministry, The Way Christian Center in West Berkeley, where he presently serves as thePastor.

Carol Gillespie, Executive Director, Asian American Donor Program

Carol Gillespie is one of the original members of the Board of Directors for the Asian American Donor Program (AADP) when it was founded in 1989. She volunteered for AADP for3 years before accepting the position as Project Administrator in 1992. In 2002, Gillespie was selected as AADPs Executive Director and is currently serving in that position.

Jess Tom, Chef, Author, and TV Guest

Jess Tom is the sister of Andrew, who at 29 years old was living his dream and engaged to the love of his life. In May 2020 Andrew went to the doctor for swollen lymph nodes. A couple of days later, he was diagnosed withmixed phenotype acute leukemia (MPAL), a rare and aggressive form of leukemia. MPAL accounts for only 2-5% of all leukemias. The only way he can beat the illness is with a stem cell transplant.

In order to have a stem cell transplant, first a stem cell match for Andrew must be found. No one in Andrews family is a match. As being a match is genetically based, Andrews stem cell match will most likely be someone who is Chinese.Chinese donors only make up 0.7% of the national donor registry, leaving him with only a 43% chance of finding a perfect match.

Jess Tom has been working with the Asian American Donor Program, a nonprofit organization, to encourage Chinese Americans to register as potential stem cell donors. Sheis a chef and winner of season 14 ofFood Network Star. Jess Tom is a writer and food blogger living in Brooklyn.

She is the author ofFOOD WHORE: A Novel of Dining & Deceitpublished by William Morrow/HarperCollins. The paperback edition was released in 2015.FOOD WHORE, Jess first novel, merges her love of food and fiction.

You can find Jess on stage, online and on television, appearing on the Food Network, Good Morning America, the Today Show, and more.She has worked on initiatives with food trucks, restaurants, hospitality startups, and citywide culinary programs.